MIB-1 labelling index is an independent prognostic marker in primary breast cancer

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

1991 • 2,598 citations

A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis

1983 • 1,681 citations

Convention on nomenclature for DNA cytometry

1984 • 601 citations

Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin‐embedded tissue

1985 • 369 citations

Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project

1992 • 359 citations

Flow cytometry using paraffin‐embedded tissue: Five years on

1989 • 282 citations

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1989 • 267 citations

Convention on nomenclature for DNA cytometry

1984 • 219 citations

Consensus review of the clinical utility of dna cytometry in carcinoma of the breast

1993 • 196 citations

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival

1995 • 183 citations

Proliferation index as a prognostic marker in breast cancer

1993 • 181 citations

Proliferation Markers in Breast Carcinoma:Mitotic Figure Count, S-Phase Fraction, Proliferating Cell Nuclear Antigen, Ki-67 and MIB-1

1995 • 180 citations

Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor

1991 • 143 citations

Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.

1996 • 112 citations

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.

1995 • 111 citations

The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancer

1995 • 111 citations

Relationship betweenp53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1996 • 97 citations

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

1993 • 92 citations

Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S‐phase fraction and that of the antibodies to Ki‐67 and PCNA antigens detected by immunocytochemistry

1994 • 87 citations

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

1997 • 81 citations

Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences

1993 • 69 citations

Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.

1996 • 69 citations

MIB-1 proliferative activity in invasive breast cancer measured by image analysis.

1996 • 65 citations

Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosis

1994 • 59 citations

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67

1991 • 55 citations

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

1996 • 51 citations

Cell kinetics: prognostic and therapeutic implications in human tumours

1994 • 33 citations

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

1993 • 33 citations

Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients

1993 • 23 citations

Routine or delayed axillary dissection for primary breast cancer?

1995 • 23 citations

Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies ? comparative studies on frozen and paraffin sections

1995 • 18 citations

THE NATURAL HISTORY OF BREAST CANCER

1999 • 18 citations

Expression of pS2 Estrogen-Inducible Protein in Primary Breast Cancer

1996 • 17 citations

Is routine axillary nodal dissection necessary in the treatment of breast cancer?

1996 • 16 citations

Is routine axillary nodal dissection necessary in the treatment of breast cancer?

1996 • 1 citations